MedPath

Zhejiang Medicine Co., Ltd.

Zhejiang Medicine Co., Ltd. logo
🇨🇳China
Ownership
Public, Subsidiary
Established
1997-05-16
Employees
6.2K
Market Cap
-
Website
http://www.lai-yi.com

Clinical Trials

4

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:3
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (75.0%)
Not Applicable
1 (25.0%)

Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis

Not Applicable
Completed
Conditions
NASH (Non-Alcoholic Steatohepatitis)
Interventions
First Posted Date
2016-11-11
Last Posted Date
2023-04-03
Lead Sponsor
Zhejiang Medicine Co., Ltd.
Target Recruit Count
120
Registration Number
NCT02962297
Locations
🇨🇳

Beijing Ditan Hospital Capital Medical University, Beijin, Beijing, China

🇨🇳

302 Military Hospital of China, Beijing, China

🇨🇳

Beijing YouAn Hospital Capital Medical Univercity, Beijing, China

and more 12 locations

Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

Phase 1
Conditions
Kidney Dysfunction
Interventions
First Posted Date
2016-07-21
Last Posted Date
2018-04-03
Lead Sponsor
Zhejiang Medicine Co., Ltd.
Target Recruit Count
24
Registration Number
NCT02840812
Locations
🇨🇳

ZheJiang Medicine, Shaoxing, China

Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function

Phase 1
Completed
Conditions
Liver Dysfunction
Interventions
First Posted Date
2015-11-13
Last Posted Date
2018-03-30
Lead Sponsor
Zhejiang Medicine Co., Ltd.
Target Recruit Count
20
Registration Number
NCT02604498
Locations
🇨🇳

Huashan Hospital, Fudan University, Shanghai, Shanghai, China

A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression

Phase 1
Terminated
Conditions
Breast Neoplasms
Stomach Neoplasms
Interventions
First Posted Date
2015-07-30
Last Posted Date
2020-06-05
Lead Sponsor
Zhejiang Medicine Co., Ltd.
Target Recruit Count
9
Registration Number
NCT02512237
Locations
🇦🇺

Mater Adult Hospital, South Brisbane, Queensland, Australia

🇦🇺

Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

🇦🇺

Monash Medical Centre, Clayton, Victoria, Australia

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.